First-in-human phase I study of SOR-C13, a TRPV6 calcium...

Investigational New Drugs 2017 / 6 Vol. 35; Iss. 3

First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors

Fu, S., Hirte, H., Welch, S., Ilenchuk, T. T., Lutes, T., Rice, C., Fields, N., Nemet, A., Dugourd, D., Piha-Paul, S., Subbiah, V., Liu, L., Gong, J., Hong, D., Stewart, J. M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-017-0438-z
Date:
June, 2017
File:
PDF, 619 KB
english, 2017
Conversion to is in progress
Conversion to is failed